HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $927,834 | +14.2% | 8,020 | +1.5% | 0.00% | +33.3% |
Q2 2023 | $812,721 | -5.7% | 7,902 | +0.1% | 0.00% | 0.0% |
Q1 2023 | $861,879 | -0.1% | 7,897 | +4.2% | 0.00% | -25.0% |
Q4 2022 | $862,490 | +34.8% | 7,579 | -26.7% | 0.00% | +33.3% |
Q3 2022 | $640,000 | -25.6% | 10,342 | -4.0% | 0.00% | 0.0% |
Q2 2022 | $860,000 | -72.6% | 10,778 | -63.8% | 0.00% | -72.7% |
Q1 2022 | $3,136,000 | +179.0% | 29,803 | +185.8% | 0.01% | +175.0% |
Q4 2021 | $1,124,000 | +11.3% | 10,427 | +13.1% | 0.00% | 0.0% |
Q3 2021 | $1,010,000 | -71.9% | 9,218 | -76.0% | 0.00% | -73.3% |
Q2 2021 | $3,593,000 | +13.7% | 38,372 | +11.8% | 0.02% | +15.4% |
Q1 2021 | $3,159,000 | +520.6% | 34,326 | +392.9% | 0.01% | +550.0% |
Q4 2020 | $509,000 | -5.9% | 6,964 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $541,000 | +43.5% | 6,964 | +2.5% | 0.00% | +50.0% |
Q2 2020 | $377,000 | +87.6% | 6,792 | 0.0% | 0.00% | +100.0% |
Q1 2020 | $201,000 | -18.3% | 6,792 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $246,000 | – | 6,792 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |